Development of V2-deleted trimeric envelope vaccine candidates from human immunodeficiency virus type 1 (HIV-1) subtypes B and C.
Microbes Infect
; 7(14): 1386-91, 2005 Nov.
Article
em En
| MEDLINE
| ID: mdl-16275150
ABSTRACT
The urgent need for a vaccine against HIV/AIDS requires that multiple strategies be employed and evaluated in a clinical setting. V2-loop deleted trimeric envelope (Env) immunogens (protein and DNA) from subtypes B and C human immunodeficiency virus type 1 (HIV-1) strains were produced for ongoing and future clinical evaluations with other HIV antigens, adjuvants and deliveries.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Anticorpos Anti-HIV
/
Produtos do Gene env
/
HIV-1
/
Vacinas contra a AIDS
Limite:
Animals
/
Humans
Idioma:
En
Ano de publicação:
2005
Tipo de documento:
Article